Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
Skip to content Antibody Discovery Nanobody Discovery Human Antibody Discovery Anti-Idiotype Antibody Discovery Custom Antibody Development Antibody Services Protein Sequencing Antibody Sequencing Polyclonal A…
Read guide →Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem. 86 , 27–68 (2017). Article CAS PubMed Google Scholar Eisele, …
Read guide →Macrocyclic peptides – unlocking the power of macrocycles In modern drug discovery macrocyclic peptides are breaking boundaries. Since the inception of RG Discovery, we have had a strong focus on peptide chemi…
Read guide →What is a peptide? Peptides are compounds with 2 to 50 amino acids linked together by peptide (amide) bonds. Peptides with 50 or more amino acids are defined as proteins. When proteins are degraded by in vivo …
Read guide →February 25, 2026 INTRODUCTION Dear Community, Welcome to Issue 2 of Synthesis: The Rise and Rise of Peptides. In recent years, increased investment in peptide manufacture has been a notable trend. We’ve rapid…
Read guide →Speed and accuracy are critical in drug development, with only 14% of candidates receiving US Food and Drug Administration approval 1 . Therefore, any efficiency improvements are of tremendous interest to a dr…
Read guide →Researchers at the Institute for Protein Design have developed a new AI-driven molecular design tool that generates completely novel bioactive peptides. The ability to create such molecules by computation alon…
Read guide →Tuesday, April 14 Day 1 Day 2 Download Brochure Emel Adaligil, PhD, Executive Director, Chemical Biology and Peptide Macrocycles, Eli Lilly and Company , Executive Director , Chemical Biology and Peptide Macro…
Read guide →In a new study in Science , we introduce an AI-assisted drug discovery approach and use it to generate over 14.9 million never-before-seen peptides with appealing pharmaceutical features, including molecules t…
Read guide →Overview of PDPS At PeptiDream, we use our proprietary drug discovery platform, PDPS (Peptide Discovery Platform System 1) to identify and develop innovative drugs based on macrocyclic peptides for our interna…
Read guide →Millions of people live with diseases driven by complex biology that have been difficult to target by traditional therapeutic approaches. In fact, an estimated 85% of human protein targets are currently consid…
Read guide →Innovation Merck scientists are exploring macrocyclic peptides, a new way to combine the properties of a biologic in a pill. September 15, 2025 Small molecules, generally taken as pills, make up nearly 90% of …
Read guide →Macrocyclic peptides have emerged as a compelling therapeutic modality for difficult protein targets, and mRNA display technologies now allow researchers to screen libraries exceeding one trillion unique seque…
Read guide →Peptides are gathering significant attention not only for their affinity and specificity towards a diverse array of target proteins but also for their tissue permeability (oral suitability) and ease of chemica…
Read guide →We’ve previously touched on DELs and some of what they’re doing to revolutionize drug discovery. mRNA display is a somewhat similar technique that is increasingly being used to discover new high affinity pepti…
Read guide →Introduction Peptides are emerging therapeutics, filling the gap between small molecular drugs and antibodies 1, 2. Historically, peptide drugs are developed from naturally occurring bioactive peptides such as…
Read guide →Reports claim that the development of peptide-based therapeutics, from discovery to commercial launch, can take approximately 10 to 15 years. Consequently, research has been centred around accelerating the pre…
Read guide →